On July 23, 2009, Hashimoto, Kazuki; Katoda, Wataru; Takahashi, Kazuhiko; Kurimoto, Ayumu published a patent.Name: Methyl 2-(3-formylphenyl)acetate The title of the patent was Preparation of adenine compounds. And the patent contained the following:
The title compounds I [A1 = (CH2)m; A2 = (CH2)n; R1 = alkyl; R2, R3 = H, alkyl; or NR2R3 = pyrrolidine, morpholine, piperidine, etc.; R4 = alkyl] are prepared by reacting (aminoalkyl)dihydropurinone derivatives with alkyl (3-formylphenyl)acetate in the presence of boron reducing agents. I are useful as pharmaceuticals (no data). Reaction of 6-amino-2-butoxy-9-(3-[(3-morpholin-4-ylpropyl)amino]propyl)-7,9-dihydro-8H-purin-8-one dimaleate with Me (3-formylphenyl)acetate in the presence of triethylamine and sodium triacetoxyborohydride gave Me (3-([[3-(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)propyl](3-morpholin-4-ylpropyl)amino]methyl)phenyl)acetate. The experimental process involved the reaction of Methyl 2-(3-formylphenyl)acetate(cas: 142327-44-4).Name: Methyl 2-(3-formylphenyl)acetate
The Article related to adenine derivative preparation pharmaceutical, aminobutoxyoxodihydropurinylpropylmorpholinylpropylaminomethylphenylacetate preparation, aminobutoxymorpholinylpropylaminopropyldihydropurinone reaction formylphenylacetate sodium triacetoxyborohydride, aminoalkyldihydropurinone derivative reaction formylphenylacetate boron reducing agent and other aspects.Name: Methyl 2-(3-formylphenyl)acetate
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics